Animal Models And It’s Screening Platforms

Infection: Customizable Immunized Mouse Models and its Screening Platforms

Helping to advance COVID-19 vaccines & therapeutics and adjuvants

Immunized mouse model with Spike1 for long and short-term projects along with its screening platforms such as ELIPSPOT (Th1 and Th2, B-cell responses), ELISA (IgG, IgM) and Neutralizing Abs, Cytokine and Chemokine analysis with MCYTMG-70K-PX32, In-vivo imaging for biodistribution, and  time-course Fluorescent microscopy imaging.

Inflammation

Applications:

 -Gene Therapy Applications
-Drug Screening for Sepsis
-Testing Therapeutic Agents for
– Inflammatory and Immunological
– Diseases

Testing platforms:

-Characterization of the Cellular Profile by Recruited Granulocytes
-Biomarker Level Detection in the Lung and BAL

Inflammation:

-Non-invasive Pulmonary inflammation and Acute Lung Injury using a Mesh-Nebulizer System.
-Bacterial Lung Infection

 

Our Models for Immunotherapy Drug and Therapeutic Development

In tumor-bearing mice, the effect of single-agent anti-PD-1 compared with control antibody on tumor growth and survival.

Morpheus Biolabs provides in vivo study platforms and ex vivo analysis services for immunotherapy drug and therapeutic development. Please inquire about our different preclinical in vivo models for immuno-oncology, including syngeneic tumor models for testing the efficacy and profiling of combination therapies. In tumor-bearing mice, the effect of single-agent anti-PD-1 compared with control antibody on tumor growth and survival.